Showing 121-130 of 9351 results for "".
- Ultra-Processed Foods May Influence Pediatric Acne Through mTORC1 Signaling: Studyhttps://practicaldermatology.com/news/ultra-processed-foods-may-influence-pediatric-acne-through-mtorc1-signaling-study/2488415/Ultra-processed foods may contribute to pediatric acne through metabolic, inflammatory, and microbiome-related pathways, according to a comprehensive review published in the International Journal of Molecular Sciences. Researchers examined current evidence connecting ultra-processed foods
- Omalizumab Shows Median 3.1-Year Drug Survival in Chronic Urticariahttps://practicaldermatology.com/news/omalizumab-shows-median-31-year-drug-survival-in-chronic-urticaria/2488414/Omalizumab demonstrated a median drug survival of more than 3 years among patients with chronic urticaria (CU), with successful disease control rather than adverse events emerging as a common reason for treatment discontinuation, according to a systematic review an
- AI Analysis Maps Environmental and Immune Signatures in Pediatric ADhttps://practicaldermatology.com/news/ai-analysis-maps-environmental-and-immune-signatures-in-pediatric-atopic-dermatitis/2488367/A machine learning (ML)-based analysis of environmental, immune, and transcriptomic data identified distinct protective and susceptibility clusters associated with pediatric atopic dermatitis (AD) among AmaXhosa children in South Africa. Published in PLoS Medicine, the observation
- NEA Expands Seal of Acceptance Program to Makeup Productshttps://practicaldermatology.com/news/nea-expands-seal-of-acceptance-program-to-makeup-products/2488269/The National Eczema Association (NEA) has expanded its Seal of Acceptance program to include color cosmetics, opening the program to makeup products for the first time since the Seal was established in 2008. The initial expan
- PCA SKIN Launches Microbiome-Focused Acne Control Cleanserhttps://practicaldermatology.com/news/pca-skin-launches-microbiome-focused-acne-control-cleanser/2488268/PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a new daily cleanser formulated to address acne while supporting the skin barrier and microbiome, according to information provided by the company. The cleanser, laun
- Cuttlefish Ink-Derived Microneedles Show Potential for Vitiligo Repigmentationhttps://practicaldermatology.com/news/cuttlefish-ink-derived-microneedles-show-potential-for-vitiligo-repigmentation/2488260/Researchers have developed a fast-dissolving microneedle platform designed to address oxidative stress, inflammation, melanocyte loss, and depigmentation in vitiligo, according to a preclinical study published in Marine Life Scie
- Maternal and Infant Skin Microbiomes Show Distinct but Connected Developmenthttps://practicaldermatology.com/news/maternal-and-infant-skin-microbiomes-show-distinct-but-connected-development/2488255/The skin microbiomes of mothers and their infants appear to be closely connected during early life, although infant microbial diversity follows its own developmental trajectory, according to a recent longitudinal study published in Experimental Dermatology. Researchers for the stu
- Medical Creators Produce Higher-Quality Alopecia Areata Content on Social Media: Studyhttps://practicaldermatology.com/news/medical-creators-produce-higher-quality-alopecia-areata-content-on-social-media/2488252/A cross-sectional study of alopecia areata content on 3 major Chinese social media platforms found that video quality, reliability, and adherence to clinical guidance varied substantially by platform and creator background. Investigators evaluated 111 high-engagement educational videos ide
- Hidradenitis Suppurativa Linked to Higher Cardiovascular Risk: Meta-Analysishttps://practicaldermatology.com/news/hidradenitis-suppurativa-linked-to-higher-cardiovascular-risk-meta-analysis/2488190/Hidradenitis suppurativa (HS) was associated with increased risk of multiple cardiovascular outcomes in a systematic review and meta-analysis encompassing 373,689 individuals with the chronic inflammatory skin disease. Cardiovascular Comorbidities and Hidradenitis Suppurativa
- INTerpath-001: Intismeran Plus Pembrolizumab Meets Dual Phase 3 Melanoma Endpointshttps://practicaldermatology.com/news/intismeran-plus-pembrolizumab-meets-dual-phase-3-melanoma-endpoints/2488176/Merck and Moderna reported positive topline results from the phase 3 INTerpath-001 trial evaluating intismeran autogene (V940; mRNA-4157) plus pembrolizumab (Keytruda) as adjuvant therapy for completely resected stage IIB-IV cutaneous melanoma. The individualized mRNA-based neoantigen ther